Nordic Study in Cardiac and Lung Transplantation: Outcome in Relation to Cyclosporine Microemulsion C2 Levels
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The main purpose of this study is to identify cyclosporine C2 levels during 12 months
treatment , while cyclosporine microemulsion dosages are adjusted based on C0 cyclosporine
blood samples, and retrospectively correlate C2 levels to outcome (renal function and
incidence of acute rejections)